Dana Aftab Exelixis, Inc. (EXEL) insider trading activity

EXEL Quotes by TradingView

Dana Aftab is CSO/EVP Disc & Trans Research of EXELIXIS, INC.. Currently has a direct ownership of 500,107 shares of EXEL, which is worth approximately $13.2 Million. The most recent transaction as insider was on Aug 12, 2024, when has been sold 20,883 shares (Common Stock) at a price of $27.06 per share, resulting in proceeds of $565,093. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 500K
4.01% 3M change
14.17% 12M change
Total Value Held $13.2 Million

Dana Aftab Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2024
SELL
Open market or private sale
$565,093 $27.06 p/Share
20,883 Reduced 4.01%
500,107 Common Stock
Aug 07 2024
SELL
Open market or private sale
$2,375,000 $25.0 p/Share
95,000 Reduced 15.42%
520,990 Common Stock
Aug 07 2024
BUY
Exercise of conversion of derivative security
$2,318,950 $24.41 p/Share
95,000 Added 13.36%
615,990 Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$474,478 $20.99 p/Share
22,605 Reduced 4.16%
520,990 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
63,350 Added 10.46%
542,381 Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$216,745 $20.39 p/Share
10,630 Reduced 2.17%
479,031 Common Stock
Jan 11 2024
SELL
Payment of exercise price or tax liability
$265,313 $22.86 p/Share
11,606 Reduced 2.32%
489,661 Common Stock
Jan 11 2024
BUY
Grant, award, or other acquisition
-
63,224 Added 11.2%
501,267 Common Stock
Sep 06 2023
SELL
Payment of exercise price or tax liability
$279,711 $22.27 p/Share
12,560 Reduced 2.79%
438,043 Common Stock
Sep 06 2023
BUY
Grant, award, or other acquisition
-
50,660 Added 10.11%
450,603 Common Stock
Aug 30 2023
SELL
Open market or private sale
$103,362 $22.47 p/Share
4,600 Reduced 1.14%
399,943 Common Stock
Aug 15 2023
SELL
Payment of exercise price or tax liability
$135,082 $21.51 p/Share
6,280 Reduced 1.53%
404,543 Common Stock
May 15 2023
SELL
Payment of exercise price or tax liability
$201,159 $19.18 p/Share
10,488 Reduced 2.49%
410,823 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
-
68,331 Added 14.0%
419,803 Common Stock
Feb 28 2023
SELL
Open market or private sale
$1,443,575 $17.5 p/Share
82,490 Reduced 19.01%
351,472 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
$1,215,902 $14.74 p/Share
82,490 Added 15.97%
433,962 Common Stock
Feb 27 2023
SELL
Open market or private sale
$175 $17.5 p/Share
10 Reduced 0.0%
351,472 Common Stock
Feb 27 2023
BUY
Exercise of conversion of derivative security
$147 $14.74 p/Share
10 Added 0.0%
351,482 Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$27,644 $18.08 p/Share
1,529 Reduced 0.43%
351,472 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 22.08%
353,001 Common Stock
DA

Dana Aftab

CSO/EVP Disc & Trans Research
Alameda, CA

Track Institutional and Insider Activities on EXEL

Follow EXELIXIS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

News

Receive news related to EXELIXIS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EXEL